International Partnership for Microbicides
Industry
- Academic and Research Institutions
Latest on International Partnership for Microbicides
The European Medicines Agency has this week recommended for EU approval a raft of new drugs, including Blenrep (belantamab mafodotin), GlaxoSmithKline ’s first-of-a-kind treatment for multiple myelom
The European Medicines Agency will this week again consider whether to recommend pan-EU marketing approval for belantamab mafodotin, GlaxoSmithKline ’s novel multiple myeloma treatment that last week
GlaxoSmithKline could find out this week whether the European Medicines Agency will recommend that its multiple myeloma drug belantamab mafodotin be approved in the EU, setting the company on course
Sponsors of seven new medicines, including three orphan drugs, will know by the end of this week whether the European Medicines Agency’s drug evaluation committee, the CHMP, has recommended their prod